KIR3DL2 may represent a novel therapeutic target in aggressive systemic peripheral T-cell lymphoma

Detalles Bibliográficos
Autores principales: Decroos, Amandine, Cheminant, Morgane, Bruneau, Julie, Carras, Sylvain, Parinet, Vincent, Pelletier, Laura, Lacroix, Laetitia, Martin, Nadine, Giustiniani, Jérôme, Lhermitte, Ludovic, Asnafi, Vahid, Battistella, Maxime, Lemonnier, François, de Leval, Laurence, Sicard, Hélène, Bonnafous, Cécile, Gauthier, Laurent, Genestier, Laurent, Caruso, Stefano, Gaulard, Philippe, Hermine, Olivier, Ortonne, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542838/
https://www.ncbi.nlm.nih.gov/pubmed/37165836
http://dx.doi.org/10.3324/haematol.2022.282220

Ejemplares similares

Ejemplares similares